Prospective Evidence on Artificial Intelligence−Assisted Melanoma Diagnostics: A Systematic Review and - Report - MDSpire

Prospective Evidence on Artificial Intelligence−Assisted Melanoma Diagnostics: A Systematic Review and

  • By

  • Sara Laiouar-Pedari

  • Arlene Kühn

  • Christoph Wies

  • Carina Nogueira Garcia

  • Jana Therés Winterstein

  • Lukas Heinlein

  • Annemarie Hoffsommer

  • Tirtha Chanda

  • Sarah Haggenmüller

  • Titus J. Brinker

  • May 1, 2026

  • 0 min

Share

Clinical Report: Evaluating the Role of Artificial Intelligence in Melanoma Diagnosis

Overview

This systematic review and meta-analysis evaluates the diagnostic performance of artificial intelligence (AI) in melanoma detection, comparing it to traditional dermoscopy. The findings suggest that AI can achieve diagnostic accuracy comparable to expert dermatologists, highlighting its potential as a decision-support tool in clinical practice.

Background

Malignant melanoma is a highly aggressive skin cancer where early detection is crucial for improving patient outcomes. Dermoscopy has enhanced diagnostic accuracy compared to visual inspection, yet its effectiveness is influenced by the clinician's experience. The integration of AI into dermatology could potentially standardize and improve diagnostic performance, addressing the limitations of human assessment.

Data Highlights

No numerical data available in the provided source material.

Key Findings

  • AI systems have shown diagnostic performances comparable to expert dermatologists in melanoma detection.
  • Most studies on AI performance have been retrospective, raising concerns about generalizability.
  • This meta-analysis focuses exclusively on prospective studies to provide more clinically relevant evidence.
  • AI-assisted dermoscopy may enhance diagnostic accuracy, with sensitivity and specificity metrics reported.
  • Current clinical guidelines still emphasize the role of experienced dermatologists over standalone AI systems.

Clinical Implications

The findings support the potential use of AI as an adjunct to traditional dermoscopy, which may enhance diagnostic accuracy in melanoma detection. Clinicians should remain aware of the evolving role of AI in dermatology while continuing to rely on their expertise and clinical judgment.

Conclusion

This systematic review underscores the promise of AI in improving melanoma diagnosis, though further validation and integration into clinical practice are necessary. Ongoing research will be essential to establish the reliability and effectiveness of AI tools in real-world settings.

Related Resources & Content

  1. Laiouar-Pedari et al., JAMA Dermatology, 2026 -- Prospective Evidence on Artificial Intelligence−Assisted Melanoma Diagnostics: A Systematic Review and Meta-Analysis
  2. ASCO AI in Oncology, 2026 -- Comparable Melanoma Detection for AI vs Dermatologists, Systemic Review Shows
  3. The ASCO Post, 2026 -- AI Shows Dermatologist-Level Accuracy in Melanoma Diagnosis but Needs Validation
  4. The ASCO Post, 2026 -- Melanoma: Can AI Enable Diagnosis Prediction?
  5. NCCN GUIDELINES® INSIGHTS, 2024 -- Melanoma: Cutaneous
  6. The ASCO Post — Machine Learning Algorithms May Help Predict Response to Immunotherapy in Patients With Advanced Melanoma
  7. CE NCCN GUIDELINES® INSIGHTS Melanoma: Cutaneous,
  8. Prospective Evidence on Artificial Intelligence−Assisted Melanoma Diagnostics: A Systematic Review and Meta-Analysis | JAMA Dermatology | JAMA Network
  9. Equity and Generalizability of Artificial Intelligence for Skin-Lesion Diagnosis Using Clinical, Dermoscopic, and Smartphone Images: A Systematic Review and Meta-Analysis - PubMed

Original Source(s)

Related Content